Stock Opinions by Liz Young, Head of investment strategy at SoFi

Most recent Opinions go here

Be up to date, don't miss your chance.

COMMENT

There's been hyper-demand for this and related stocks. At some prices, these high share prices have to come down, take a breather, and that's fine. Long term, there's plenty of life here.

DON'T BUY

Data is soft: new home sales below estimates and home supply the highest since 2022. This suggests home prices will fall, which 

BUY

The yield curve will steepen with the short end coming down which will spur capital markets activity.

BUY

Its top two sectors are her favourites: tech and healthcare.

COMMENT

Companies like this will continue to experiment with AI and blockchain. They have to balance this with trust and safety. Time will tell how it shakes out.

COMMENT

They report later today. Is up 135% this year.They have strong relationships trading in semis with Amazon and Microsoft's Azure. Options implies a 12% move. There will be speculation in Marvell. The spotlight is on these chips names.

COMMENT

Demands is outstripping supply, driving prices up. Is this the right time enter a stock that's up so much (220% this year)? No technician will say it is. That said, the fundamentals support MU right now. Twelve months from now, capex can continue at this clip, though she is skeptical earnings can continue to grow 20-30% every quarter. Semis need a cooling off period.

BUY

A great way to play AI in China. China is the low-cost producer. Demand will continue to ramp up. Both China and the US can win in AI.

BUY

South Korean exports have seen the largest growth YOY since maybe 2010. Strong. There's more earnings growth ahead as demand grows for memory (SK is strong in memory).

BUY

When the year started, she made a bullish call on materials, which the market expected to be among the top three sectors, above 30% earnings growth projected this year. Keep buying this.

BUY

Buy this before tech earnings report. She expects strong earnings.

BUY ON WEAKNESS

In the past month, software has been oversold and won't wait for Nvidia's result to rebound. IGV is bottoming.

BUY

Healthcare was one of her calls for 2026 but didn't rise until early August. Is up 15.3% this year. HC remains a buy for 2026.

BUY

It holds companies with free high cash flows. Also, the biggest sector here is healthcare--is bullish.

BUY

Healthcare is not a value trap. It's the worst performing sector this year--and could get worse--but the knife has fallen. If you're looking for something to buy in a market with high valuations and possible headlines from inflation prints, look at healthcare. Healthcare is insulated from interest rate volatility. If you're worried about Trump's attitude to phama, then look at healthcare equipment and services and buy IHI.

Showing 1 to 15 of 37 entries